incompatible 发表于 2025-3-21 16:28:00

书目名称Medical Science and Research影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0629372<br><br>        <br><br>书目名称Medical Science and Research影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0629372<br><br>        <br><br>书目名称Medical Science and Research网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0629372<br><br>        <br><br>书目名称Medical Science and Research网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0629372<br><br>        <br><br>书目名称Medical Science and Research被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0629372<br><br>        <br><br>书目名称Medical Science and Research被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0629372<br><br>        <br><br>书目名称Medical Science and Research年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0629372<br><br>        <br><br>书目名称Medical Science and Research年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0629372<br><br>        <br><br>书目名称Medical Science and Research读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0629372<br><br>        <br><br>书目名称Medical Science and Research读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0629372<br><br>        <br><br>

逃避系列单词 发表于 2025-3-21 23:17:25

Mandibular Advancement Devices in Patients with Symptoms of Obstructive Sleep Apnea: A Review,previous epidemiological studies confirm a significant impact of OSA on the health situation around the world. Untreated OSA is associated with many adverse health effects, such as hypertension, coronary artery disease, stroke, atrial fibrillation, congestive heart failure, and daytime sleepiness. E

监禁 发表于 2025-3-22 03:07:11

http://reply.papertrans.cn/63/6294/629372/629372_3.png

规章 发表于 2025-3-22 04:41:15

http://reply.papertrans.cn/63/6294/629372/629372_4.png

Spinal-Tap 发表于 2025-3-22 12:26:52

Plasminogen Activator Inhibitor Type 1 in Blood at Onset of Chemotherapy Unfavorably Affects Survivtes tumor progression. The aim of this study was to evaluate the prognostic value of blood plasma PAI-1 content in patients with epithelial ovarian cancer who start the first-line chemotherapy. PAI-1 content was measured in the blood of 61 patients with epithelial ovarian cancer at onset of first-li

Granular 发表于 2025-3-22 12:58:17

Sialidase Attenuates Epidermal Growth Factor Response and Abolishes Antiproliferative Effects of ErR). The drug is approved for the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR mutations. Extracellular glycans can affect EGFR expression, dimerization, phosphorylation, and EGF binding. In this study we investigated the effects of EGF and erlotinib on the ce

耐寒 发表于 2025-3-22 20:53:31

Systemic Sclerosis and Serum Content of Transforming Growth Factor,(TGF-β) has been of interest as a potential diagnostic marker and also as a drug target in systemic sclerosis. The aim of this study was to assess the serum content of TGF-β1 in patients with systemic sclerosis and to assess its potential role in tissue fibrosis. The study included 30 patients, 5 me

壕沟 发表于 2025-3-23 00:55:12

Protein-Bound Solute Clearance During Hemodialysis,rimental effect on the kidney and other organs’ function. This study seeks to define the effectiveness of IS and p-CS clearance after single dialysis sessions and after 8-week-long cycles of hemodialysis using the following different dialysis modalities in succession: low-flux hemodialysis (lfHD), h

abduction 发表于 2025-3-23 03:09:30

Mold Sensitization in Asthmatic and Non-asthmatic Subjects Diagnosed with Extract-Based Versus Compergen extracts are difficult to standardize, but component-resolved allergy diagnosis may be an alternative to replace extract-based tests. In this research, asthmatic and non-asthmatic subjects were studied for their sensitization to . (Asp f), . (Cla h), . (Pen ch), . (Alt a), and . (Asp v). Extra

阴谋小团体 发表于 2025-3-23 07:46:04

http://reply.papertrans.cn/63/6294/629372/629372_10.png
页: [1] 2 3 4 5
查看完整版本: Titlebook: Medical Science and Research; Mieczyslaw Pokorski Book 2019 The Editor(s) (if applicable) and The Author(s), under exclusive license to Sp